-
Bortezomib CAS:179324-69-7
Bortezomib is a pharmaceutical compound used in the treatment of multiple myeloma and mantle cell lymphoma. It belongs to the class of proteasome inhibitors, targeting proteolytic enzymes in cells to disrupt their function and induce apoptosis (programmed cell death). This mechanism makes it effective against certain cancers where uncontrolled cell growth occurs.
-
Methyl 2-bromomethyl-3-nitrobenzoate CAS:98475-07-1
Methyl 2-bromomethyl-3-nitrobenzoate is a chemical compound featuring a nitro group at the 3-position and a bromomethyl group at the 2-position of a benzoate backbone. It is utilized in organic synthesis as a versatile intermediate, enabling the construction of complex molecules with specific functional groups.
-
Pemetrexed disodium INT-5 CAS:165049-28-5
Pemetrexed disodium INT-5 is an oncology medication classified under antifolate chemotherapy agents. It is primarily used in the treatment of various cancers, including mesothelioma, non-small cell lung cancer, and specific metastatic cancers.
-
Pemetrexed disodium INT-4 CAS:137281-39-1
Pemetrexed disodium INT-4 is an antifolate chemotherapy agent used in oncology. It is employed in the treatment of various cancers, including mesothelioma, non-small cell lung cancer, and specific metastatic cancers.
-
Pemetrexed disodium INT-3 CAS:155405-80-4
Pemetrexed disodium INT-3 is an antifolate chemotherapy agent used in oncology. It is employed in the treatment of various cancers, including mesothelioma, non-small cell lung cancer, and specific metastatic cancers.
-
Terbinafine base CAS:91161-71-6
Terbinafine base is an active pharmaceutical ingredient used to treat fungal infections. It belongs to the allylamine class of antifungals and is known for its effectiveness against dermatophytes, yeasts, and molds.
-
2-Chloro-4,6-dimethoxy-1,3,5-triazine CAS:3140-73-6
2-Chloro-4,6-dimethoxy-1,3,5-triazine is a chemical compound utilized as a versatile building block in organic synthesis and chemical modification processes. It features chloro and methoxy functional groups attached to a triazine ring structure, enabling its application in diverse chemical reactions and compound formations.
-
2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile CAS:950596-58-4
2-Amino-4,5-bis(2-methoxyethoxy)benzonitrile is a chemical compound utilized in pharmaceutical research, characterized by a benzonitrile structure with amino and methoxyethoxy substitutions, potentially significant for specific therapeutic applications.
-
(1R)-(S)-pinanediol-1-Ammonium Trifluoroacetate-3-methlbutane-1-boronate CAS:179324-87-9
(1R)-(S)-Pinanediol-1-Ammonium Trifluoroacetate-3-Methylbutane-1-Boronate is a chemical compound characterized by a complex structure featuring a pinanediol backbone, an ammonium trifluoroacetate group, and a boronate ester functionality. It is utilized in organic synthesis as a chiral building block, enabling the creation of stereospecific compounds and pharmaceutical intermediates.
-
Diethyl L-glutamate hydrochloride CAS:1118-89-4
Diethyl L-glutamate hydrochloride is a chemical compound used primarily as a synthetic intermediate in pharmaceutical research and organic synthesis. It is derived from L-glutamic acid and serves as a precursor in the production of various pharmaceuticals and biologically active compounds.
-
3,3-Dimethyl-1-Butyne CAS:917-92-0
3,3-Dimethyl-1-butyne is a chemical compound notable for its triple bond structure and two methyl groups attached to the carbon atoms of the triple bond. It is commonly referred to as tetramethylethyne and is used in various chemical synthesis processes.
-
6-Chloro-3-methyluracil CAS:4318-56-3
6-Chloro-3-methyluracil is a derivative of uracil, a pyrimidine base, with chlorine and methyl groups attached to specific positions on the uracil ring. This modification imparts distinct chemical and biological properties to the compound, making it significant in medicinal chemistry and biochemical research. 6-Chloro-3-methyluracil’s structure influences its interactions within biological systems, particularly in nucleic acid synthesis and enzyme inhibition, which are critical aspects in drug design and therapeutic development.
